Back to results
US 2017/0283457 A1Published application
Use of inhibitory peptides for the treatment of inflammatory diseases
AssigneeYeda Research and Development Co. Ltd.
InventorsRony SEGER, Eldar ZEHORAI
Life of this patent
Estimating the term…
Abstract
An isolated peptide is disclosed which comprises an amino acid sequence being at least 80% homologous to the sequence as set forth in SEQ ID NO: 1 (PERYQNLSPV), the isolated peptide comprising a nuclear targeting activity, the peptide being no longer than 20 amino acids.
Claims16
An isolated peptide comprising an amino acid sequence being at least 80% homologous to the sequence as set forth in SEQ ID NO:
- 1 (PERYQNLSPV), the isolated peptide comprising a nuclear targeting activity, the peptide being no longer than 20 amino acids.
Dependencies are inferred from the claim text.